// RESEARCH_CATEGORY
Longevity & Aging
Research on healthspan, lifespan, and age-related interventions.
Rapamycin and Cellular Senescence: Phase 2 Clinical Trial
Phase 2 RCT examining low-dose rapamycin effects on senescent cell markers, immune function, and biological aging in healthy older adults.
Rapamycin and Cellular Senescence: Insights from Clinical Trials
A phase 2 clinical trial examining the effects of low-dose rapamycin on markers of cellular senescence, immune function, and age-related biomarkers in healthy older adults.
NAD+ Precursors and Biological Aging: NMN vs NR Comparison
Head-to-head trial comparing nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) for raising NAD+ levels and improving aging biomarkers.
Caloric Restriction and Epigenetic Age: CALERIE-2 Results
Analysis of CALERIE-2 trial examining 25% caloric restriction effects on epigenetic aging clocks over 2 years in non-obese adults.
Senolytics Dasatinib+Quercetin: First Human Trial Results
First-in-human trial of senolytic combination dasatinib plus quercetin for clearing senescent cells in idiopathic pulmonary fibrosis patients.
Metformin and Aging: TAME Trial Preliminary Results
Preliminary results from TAME (Targeting Aging with Metformin) trial examining metformin effects on age-related diseases in non-diabetic older adults.